De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000

Closure of Patent Foramen Ovale for Pardoxical Emboli: Intermediate-Term Risk of Recurrent Neurological Events Following Transcatheter Device Placement
J Am Coll Cardiol 35:1311-1316, Hung,J.,et al, 2000

Ocular Involvement in Sarcoidosis
Br J Ophthalmol 84:110-116, Rothova, A., 2000

The Central Nervous system and Infection by Candida Species
Diagn Microbial Infect Dis 37:169-179, Sanchez-Portocarrero, J.,et al, 2000

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Rapidly Progressive Multifocal Leukoencephalopathy with Substantial Cell-Mediated Inflammatory Response and With Cognitive Decline of Non-Alzheimer Type in a 75-Year-Old Female Patient
Clin Neuropathol 18:113-123, Alafuzoff,I.,et al, 1999

Progressive Multifocal Leukoencephalopathy in Elderly Immunocompetent Patients. Report of 2 Cases
Rev Neurol 29:133-137, Bosch,J.,et al, 1999

Immediate Reoperation for Perioperative Stroke After 2250 Carotid Endarterectomies: Differences Between Intraoperative and Early Postoperative Stroke
J Vasc Surg 30:245-251, Radak,D.,et al, 1999

Longitudinal Magnetic Resonance Imaging Study of Perfusion and Diffusion in Stroke:Evolution of Lesion Volume and Correlation with Clinical Outcome
Ann Neurol 46:568-578,556, Beaulieu,C.,et al, 1999

The Intensive Care Management of Acute Ischemic Stroke
The Neurologist 5:313-325, Deibert,E.&Diringer,M.N., 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Progressive Multifocal Leukoencephalopathy in AIDS:Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?
AJNR 20:1896-1906, Post,M.J.D.,et al, 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Unilateral Pallidotomy for Parkinson's Disease:Results after More Than 1 Year
JNNP 67:511-517, Schrag,A.,et al, 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999

Relevance of Hypointense Lesions on Fast Fluid-Attenuated Inversion Recovery MR Images as a Marker of Disease Severity in Cases of Multiple Sclerosis
AJNR 20:813-820, Rovaris,M.,et al, 1999

Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999

Ventricular Asystole During Vagus Nerve Stimulation for Epilepsy in Humans
Neurol 52:1267-1269,1117, Tatum,IV,W.O.,et al, 1999

Arteriovenous Malformations of the Brain in Adults
NEJM 340:1812-1818, The Arteriovenous Malformation Study Group, 1999

Risk of Subarachnoid Hemorrhage After Surgical Treatment of Unruptured Cerebral Aneurysms
Stroke 30:1181-1184, Tsutsumi,K.,et al, 1999

Surgical and Endovascular Treatment of Unruptured Cerebral Aneurysms at University Hospitals
Neurol 52:1799-1805, Johnston,S.C.,et al, 1999

The Relationship of MS to Physical Trauma and Psychological Stress, Report of the Therapeutics and Technology Assessment Subcommittee of the AAN
Neurol 52:1737-1745, Goodin,D.S.,et al, 1999

Trigeminal Neuralgia Triggered by Auditory Stimuli in Multiple Sclerosis
Arch Neurol 56:731-733, Hartmann,M.,et al, 1999

Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999

Cavernous Haemangioma Mimicking Multiple Sclerosis
BMJ 318:1604-1605, Cader,M.Z.&Winer,J.B., 1999

Baseline NIH Stroke Scale Score Strongly Predicts Outcome after Stroke, A Report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)
Neurol 53:126-131, Adams,Jr.,H.P.,et al, 1999

Lamotrigine Adjunctive Therapy in painful Phenomena in MS:Preliminary Observations
Neurol 53:433, Cianchetti,C.,et al, 1999

Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999

Chlamydia Pneumoniae Infection of the Central Nervous System in Multiple Sclerosis
Ann Neurol 46:6-14,4, Sriram,S.,et al, 1999

A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

Benign Multiple Sclerosis? Clinical Course, Long Term Follow Up, and Assessment of Prognostic Factors
JNNP 67:148-152,138, Hawkins,S.A.&McDonnell,G.V., 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999

Comparative Effects of Unilateral and Bilateral Subthalamic Nucleus Deep Brain Stimulation
Neurol 53:561-566, Kumar,R.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

Optic Nerve Enlargement in Krabbe's Disease
AJNR 20:1228-1231, Jones,B.V.,et al, 1999

The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

The North American Symptomatic Carotid Endarterectomy Trial, Surgical Results in 1415 Patients
Stroke 30:1751-1758,1745, Ferguson,G.G.,et al, 1999

Carotid Endarterectomy, Where Do We Draw The Line?
Stroke 30:1745-1750, Gorelick,P.B., 1999

Medical Complications Associated with Carotid Endarterectomy
Stroke 30:1759-1763, Paciaroni,M.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999